D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:D. Western Therapeutics Institute Inc (4576) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8019
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI’s ophthalmic solution treats glaucoma and ocular hypertension treatment and arteriosclerosis obliterans. The company’s glanatek is an opthalmic solution with composition of ripasudil hydrochloride hydrate developed for the treatment of glaucoma through its intraocular pressure lowering action. It offers licensing out and promotion of development. The company operates in Japan, The US, Korea and Europe. DWTI is headquartered in Nagoya, Japan.

D. Western Therapeutics Institute Inc (4576) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
D. Western Therapeutics Institute Inc, Medical Devices Deals, 2012 to YTD 2018 9
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
D.Western Therapeutics Institute Acquires Ophthalmic Surgical Adjuvant Business from Healios for USD11 Million 12
Partnerships 13
D. Western Therapeutics Institute Enters into Option Agreement with Allysta Pharma 13
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 14
Edit Force Enters into Research Agreement with Japan Innovative Therapeutics 15
D.Western Therapeutics Institute Enters into Research Agreement with Chiba University 16
D.Western Therapeutics Institute Enters into Research Agreement with University of Toyama 17
D. Western Therapeutics Institute Enters into Strategic Agreement with Allysta Pharma 18
Licensing Agreements 19
Japan Innovative Therapeutics Enters into Licensing Agreement with Institute of Neuroimmunology 19
D.Western Therapeutics Institute Plans to Enter into Option Agreement for H-1129 20
Wakamoto Pharma Enters into Licensing Agreement with D. Western Therapeutics Institute 21
D.Western Therapeutics Institute Enters into Licensing Agreement with Doshisha University 22
Equity Offering 23
D.Western Therapeutics Institute Raises USD2 Million in Private Placement of Shares, upon Exercise of Warrants 23
D. Western Therapeutics Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 24
D. Western Therapeutics Raises USD2.3 Million in Private Placement of Shares upon Exercise of Warrants 25
D. Western Therapeutics Raises Funds through Private Placement of Shares upon Exercise of Warrants 26
Acquisition 27
ROHTO Pharma Acquires 59.43% Stake in Japan Innovative Therapeutics for USD44 Million 27
D. Western Therapeutics Institute Inc – Key Competitors 28
D. Western Therapeutics Institute Inc – Key Employees 29
D. Western Therapeutics Institute Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
D. Western Therapeutics Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 8
D. Western Therapeutics Institute Inc, Medical Devices Deals, 2012 to YTD 2018 9
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
D.Western Therapeutics Institute Acquires Ophthalmic Surgical Adjuvant Business from Healios for USD11 Million 12
D. Western Therapeutics Institute Enters into Option Agreement with Allysta Pharma 13
Glaukos Enters into Development Agreement with D. Western Therapeutics Institute 14
Edit Force Enters into Research Agreement with Japan Innovative Therapeutics 15
D.Western Therapeutics Institute Enters into Research Agreement with Chiba University 16
D.Western Therapeutics Institute Enters into Research Agreement with University of Toyama 17
D. Western Therapeutics Institute Enters into Strategic Agreement with Allysta Pharma 18
Japan Innovative Therapeutics Enters into Licensing Agreement with Institute of Neuroimmunology 19
D.Western Therapeutics Institute Plans to Enter into Option Agreement for H-1129 20
Wakamoto Pharma Enters into Licensing Agreement with D. Western Therapeutics Institute 21
D.Western Therapeutics Institute Enters into Licensing Agreement with Doshisha University 22
D.Western Therapeutics Institute Raises USD2 Million in Private Placement of Shares, upon Exercise of Warrants 23
D. Western Therapeutics Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 24
D. Western Therapeutics Raises USD2.3 Million in Private Placement of Shares upon Exercise of Warrants 25
D. Western Therapeutics Raises Funds through Private Placement of Shares upon Exercise of Warrants 26
ROHTO Pharma Acquires 59.43% Stake in Japan Innovative Therapeutics for USD44 Million 27
D. Western Therapeutics Institute Inc, Key Competitors 28
D. Western Therapeutics Institute Inc, Key Employees 29
D. Western Therapeutics Institute Inc, Subsidiaries 30

List of Figures
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
D. Western Therapeutics Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
D. Western Therapeutics Institute Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Australia and New Zealand Banking Group Limited:企業のM&A・提携・投資分析
    Australia and New Zealand Banking Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Australia and New Zealand Banking Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • Fluxion Biosciences, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Fluxion Biosciences, Inc. (Fluxion) is a biotechnology company. The company provides analytical, live cell analysis tools to facilitate research discoveries and diagnostics. Its products include bioflux, ionflux and isoflux. The company’s bioflux is used for for live cell analysis under shea …
  • TUI Travel PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TUI Travel PLC Mergers and Acqu …
  • MacroGenics Inc (MGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for th …
  • Norsemont Mining, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Norsemont Mining, Inc. Mergers …
  • NW Tech Capital, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NW Tech Capital, Inc. Mergers a …
  • Bendigo and Adelaide Bank Limited:企業の戦略・SWOT・財務分析
    SummaryBendigo and Adelaide Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Nuvilex, Inc. (formerly eFoodSafety.com, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nuvilex, Inc. (formerly eFoodSa …
  • Dubai Electricity and Water Authority:企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Mothercare plc (MTC):企業の財務・戦略的SWOT分析
    Mothercare plc (MTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hyundai Steel Company:企業の戦略・SWOT・財務分析
    SummaryHyundai Steel Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • NBT Bancorp Inc:企業の戦略・SWOT・財務情報
    NBT Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary NBT Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cardica, Inc. (CRDC):企業の財務及び戦略的SWOT分析
    Summary Cardica, Inc. Key Recent Developments Dec 14, 2015: Cardica Signs National Agreement With Novation Nov 05, 2015: Cardica Announces Fiscal 2016 First Quarter Financial Results And Business Progress Oct 05, 2015: Cardica Appoints Experienced Medical Device Executive Julian Nikolchev As Preside …
  • Sevion Therapeutics Inc (SVON):企業財務及び戦略的SWOT分析
    Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic …
  • University of New Mexico-製薬・医療分野:企業M&A・提携分析
    Summary University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin America …
  • Wai Yuen Tong Medicine Holdings Limited (897):企業概要、財務及び戦略的SWOT分析
    Summary Wai Yuen Tong Medicine Holdings Limited (Wai Yuen Tong) is a pharmaceutical company. The company offers products such as classic series, prophylactic series, bird's nest series, beauty and slim series, metro series, soup series, men's series, flu series and premium gift series. It provides t …
  • Pharmaceutical Product Development, LLC:企業のM&A・提携・投資分析
    Pharmaceutical Product Development, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pharmaceutical Product Development, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Hitachi High-Technologies Corporation (8036):企業のM&A・提携動向(発電分野)
    Summary Hitachi High-Technologies Corporation (Hitachi High-Tech), a subsidiary of Hitachi, Ltd. is a technology company that manufactures and markets semiconductor equipment. The company’s products comprise semiconductor device manufacturing equipment, science and medical equipment, and industry an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆